Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | ISO | Nkd1 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of NKD1 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [APC protein affects the susceptibility to 1 and 2-Dimethylhydrazine] which results in increased expression of NKD1 mRNA | CTD | PMID:27840820 | 1,2-dimethylhydrazine | multiple interactions | ISO | Nkd1 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of NKD1 mRNA] | CTD | PMID:22206623 | 1,2-dimethylhydrazine | increases expression | ISO | Nkd1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of NKD1 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | NKD1 (Homo sapiens) | 6480464 | ESR1 protein affects the reaction [Estradiol promotes the reaction [NCOA2 protein binds to NKD1 gene]] more ... | CTD | PMID:17962382 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of NKD1 mRNA | CTD | PMID:32741896 | 17beta-estradiol | decreases expression | ISO | Nkd1 (Mus musculus) | 6480464 | Estradiol results in decreased expression of NKD1 mRNA | CTD | PMID:19484750 | 17beta-estradiol | increases expression | ISO | NKD1 (Homo sapiens) | 6480464 | Estradiol results in increased expression of NKD1 mRNA | CTD | PMID:17962382 and PMID:31614463 | 17beta-estradiol | decreases expression | ISO | NKD1 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of NKD1 mRNA | CTD | PMID:20106945 | 17beta-estradiol 3-benzoate | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of NKD1 mRNA | CTD | PMID:32741896 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Nkd1 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Nkd1 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Nkd1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NKD1 mRNA | CTD | PMID:19933214 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NKD1 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Nkd1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NKD1 mRNA | CTD | PMID:21570461 | 2-tert-butylhydroquinone | increases expression | ISO | Nkd1 (Mus musculus) | 6480464 | 2-tert-butylhydroquinone results in increased expression of NKD1 mRNA | CTD | PMID:16014739 | 4,4'-sulfonyldiphenol | increases expression | ISO | Nkd1 (Mus musculus) | 6480464 | bisphenol S results in increased expression of NKD1 mRNA | CTD | PMID:30951980 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Nkd1 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of NKD1 exon | CTD | PMID:33297965 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of NKD1 mRNA | CTD | PMID:31881176 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of NKD1 mRNA | CTD | PMID:28959563 | aflatoxin B1 | decreases methylation | ISO | NKD1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of NKD1 intron | CTD | PMID:30157460 | Aflatoxin B2 alpha | increases methylation | ISO | NKD1 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of NKD1 intron | CTD | PMID:30157460 | antirheumatic drug | increases expression | ISO | NKD1 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of NKD1 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | NKD1 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of NKD1 mRNA | CTD | PMID:33212167 | arsane | affects methylation | ISO | NKD1 (Homo sapiens) | 6480464 | Arsenic affects the methylation of NKD1 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | NKD1 (Homo sapiens) | 6480464 | Arsenic affects the methylation of NKD1 gene | CTD | PMID:25304211 | arsenite(3-) | increases methylation | ISO | NKD1 (Homo sapiens) | 6480464 | arsenite results in increased methylation of NKD1 promoter | CTD | PMID:23974009 | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of NKD1 gene | CTD | PMID:35440735 | benzo[a]pyrene | increases expression | ISO | Nkd1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of NKD1 mRNA | CTD | PMID:22610609 | benzo[a]pyrene | increases methylation | ISO | NKD1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of NKD1 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | NKD1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of NKD1 mRNA | CTD | PMID:20106945 more ... | benzo[a]pyrene diol epoxide I | decreases expression | ISO | NKD1 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:26238291 | benzo[b]fluoranthene | increases expression | ISO | Nkd1 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of NKD1 mRNA | CTD | PMID:26377693 | benzo[e]pyrene | increases methylation | ISO | NKD1 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of NKD1 intron | CTD | PMID:30157460 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | NKD1 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of NKD1 mRNA | CTD | PMID:31163220 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of NKD1 mRNA | CTD | PMID:25181051 more ... | bisphenol A | decreases methylation | ISO | NKD1 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of NKD1 gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | Nkd1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of NKD1 mRNA | CTD | PMID:30951980 and PMID:32156529 | bisphenol A | affects expression | ISO | NKD1 (Homo sapiens) | 6480464 | bisphenol A affects the expression of NKD1 mRNA | CTD | PMID:30903817 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of NKD1 gene | CTD | PMID:28505145 | bisphenol F | increases expression | ISO | Nkd1 (Mus musculus) | 6480464 | bisphenol F results in increased expression of NKD1 mRNA | CTD | PMID:30951980 | butanal | increases expression | ISO | NKD1 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of NKD1 mRNA | CTD | PMID:26079696 | caffeine | decreases phosphorylation | ISO | NKD1 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of NKD1 protein | CTD | PMID:35688186 | carbon nanotube | decreases expression | ISO | Nkd1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | carbon nanotube | increases expression | ISO | Nkd1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | casticin | increases expression | ISO | NKD1 (Homo sapiens) | 6480464 | casticin results in increased expression of NKD1 mRNA | CTD | PMID:27862857 | celastrol | multiple interactions | ISO | Nkd1 (Mus musculus) | 6480464 | celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of NKD1 mRNA] | CTD | PMID:31715269 | chlorpyrifos | decreases expression | ISO | Nkd1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of NKD1 mRNA | CTD | PMID:32715474 | ciguatoxin CTX1B | affects expression | ISO | Nkd1 (Mus musculus) | 6480464 | Ciguatoxins affects the expression of NKD1 mRNA | CTD | PMID:18353800 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of NKD1 mRNA | CTD | PMID:24386269 | copper(II) sulfate | decreases expression | ISO | NKD1 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of NKD1 mRNA | CTD | PMID:19549813 | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of NKD1 mRNA | CTD | PMID:26577399 and PMID:27523638 | cyclosporin A | increases expression | ISO | NKD1 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of NKD1 mRNA | CTD | PMID:25562108 | dextran sulfate | multiple interactions | ISO | Nkd1 (Mus musculus) | 6480464 | [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of NKD1 mRNA and celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of NKD1 mRNA] | CTD | PMID:31715269 | dibenz[a,h]anthracene | increases expression | ISO | Nkd1 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | dicrotophos | increases expression | ISO | NKD1 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of NKD1 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | NKD1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | folic acid | multiple interactions | ISO | Nkd1 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of NKD1 mRNA] | CTD | PMID:22206623 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of NKD1 mRNA | CTD | PMID:33387578 | hydrogen peroxide | affects expression | ISO | NKD1 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of NKD1 mRNA | CTD | PMID:23410634 | hydroquinone O-beta-D-glucopyranoside | decreases expression | ISO | NKD1 (Homo sapiens) | 6480464 | Arbutin results in decreased expression of NKD1 mRNA | CTD | PMID:17103032 | leflunomide | increases expression | ISO | NKD1 (Homo sapiens) | 6480464 | leflunomide results in increased expression of NKD1 mRNA | CTD | PMID:28988120 | lithium chloride | increases expression | ISO | NKD1 (Homo sapiens) | 6480464 | Lithium Chloride results in increased expression of NKD1 mRNA | CTD | PMID:24534281 | lithium chloride | multiple interactions | ISO | NKD1 (Homo sapiens) | 6480464 | Niclosamide inhibits the reaction [Lithium Chloride results in increased expression of NKD1 mRNA] and XAV939 inhibits the reaction [Lithium Chloride results in increased expression of NKD1 mRNA] | CTD | PMID:24534281 | menadione | affects expression | ISO | NKD1 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of NKD1 mRNA | CTD | PMID:23410634 | methapyrilene | increases methylation | ISO | NKD1 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of NKD1 intron | CTD | PMID:30157460 | naphthalene | increases expression | ISO | Nkd1 (Mus musculus) | 6480464 | naphthalene results in increased expression of NKD1 mRNA | CTD | PMID:18978301 | niclosamide | multiple interactions | ISO | NKD1 (Homo sapiens) | 6480464 | Niclosamide inhibits the reaction [Lithium Chloride results in increased expression of NKD1 mRNA] | CTD | PMID:24534281 | niclosamide | increases expression | ISO | NKD1 (Homo sapiens) | 6480464 | Niclosamide results in increased expression of NKD1 mRNA | CTD | PMID:22576131 | ozone | decreases expression | EXP | | 6480464 | Ozone results in decreased expression of NKD1 mRNA | CTD | PMID:31397875 | ozone | multiple interactions | ISO | Nkd1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of NKD1 mRNA | CTD | PMID:34911549 | panobinostat | multiple interactions | ISO | NKD1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NKD1 mRNA | CTD | PMID:27188386 | panobinostat | increases expression | ISO | NKD1 (Homo sapiens) | 6480464 | panobinostat results in increased expression of NKD1 mRNA | CTD | PMID:26272509 | paracetamol | affects expression | ISO | Nkd1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of NKD1 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of NKD1 mRNA | CTD | PMID:33387578 | PCB138 | multiple interactions | ISO | Nkd1 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | pentanal | increases expression | ISO | NKD1 (Homo sapiens) | 6480464 | pentanal results in increased expression of NKD1 mRNA | CTD | PMID:26079696 | phenobarbital | multiple interactions | ISO | Nkd1 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NKD1 mRNA] and NR1I3 protein promotes the reaction [Phenobarbital results in increased expression of NKD1 mRNA] | CTD | PMID:19482888 | phenobarbital | increases expression | ISO | Nkd1 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of NKD1 mRNA | CTD | PMID:19482888 | pirinixic acid | decreases expression | ISO | Nkd1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of NKD1 mRNA | CTD | PMID:23811191 | propanal | increases expression | ISO | NKD1 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of NKD1 mRNA | CTD | PMID:26079696 | resveratrol | multiple interactions | ISO | NKD1 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of NKD1 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | ISO | NKD1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | NKD1 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of NKD1 mRNA | CTD | PMID:25895662 | succimer | multiple interactions | ISO | Nkd1 (Mus musculus) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NKD1 mRNA | CTD | PMID:26378955 | sulforaphane | decreases expression | ISO | Nkd1 (Mus musculus) | 6480464 | sulforaphane results in decreased expression of NKD1 mRNA | CTD | PMID:30529165 | tamoxifen | increases expression | ISO | NKD1 (Homo sapiens) | 6480464 | Tamoxifen results in increased expression of NKD1 mRNA | CTD | PMID:17962382 | tert-butyl hydroperoxide | affects expression | ISO | NKD1 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide affects the expression of NKD1 mRNA | CTD | PMID:23410634 | testosterone | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of NKD1 mRNA | CTD | PMID:32741896 | titanium dioxide | increases expression | ISO | Nkd1 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of NKD1 mRNA | CTD | PMID:23557971 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of NKD1 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | NKD1 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of NKD1 mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | ISO | NKD1 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NKD1 mRNA | CTD | PMID:27188386 | triclosan | decreases expression | ISO | NKD1 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of NKD1 mRNA | CTD | PMID:30510588 | trimellitic anhydride | decreases expression | ISO | Nkd1 (Mus musculus) | 6480464 | trimellitic anhydride results in decreased expression of NKD1 mRNA | CTD | PMID:19042947 | valproic acid | increases expression | ISO | Nkd1 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of NKD1 mRNA | CTD | PMID:20546886 and PMID:21427059 | valproic acid | multiple interactions | ISO | NKD1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NKD1 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | NKD1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of NKD1 mRNA | CTD | PMID:23179753 more ... | valproic acid | increases methylation | ISO | NKD1 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of NKD1 gene | CTD | PMID:29154799 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of NKD1 mRNA | CTD | PMID:23034163 | vorinostat | multiple interactions | ISO | NKD1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NKD1 mRNA | CTD | PMID:27188386 | vorinostat | decreases expression | ISO | NKD1 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of NKD1 mRNA | CTD | PMID:27188386 | vorinostat | increases expression | ISO | NKD1 (Homo sapiens) | 6480464 | vorinostat results in increased expression of NKD1 mRNA | CTD | PMID:26272509 | XAV939 | multiple interactions | ISO | NKD1 (Homo sapiens) | 6480464 | XAV939 inhibits the reaction [Lithium Chloride results in increased expression of NKD1 mRNA] | CTD | PMID:24534281 | xylitol | increases expression | ISO | NKD1 (Homo sapiens) | 6480464 | Xylitol results in increased expression of NKD1 mRNA | CTD | PMID:32275922 | |